Eastern Bank’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$670K Buy
3,756
+1,500
+66% +$245K 0.01% 244
2026
Q2
$338K Sell
2,256
-94
-4% -$10.2K 0.01% 332
2026
Q1
$217K Buy
2,350
+190
+9% +$19.1K ﹤0.01% 365
2025
Q4
$221K Buy
2,160
+139
+7% +$12.4K ﹤0.01% 353
2025
Q3
$126K Buy
+2,021
New +$110K ﹤0.01% 423

Other funds holding GH

Eastern Bank's GH Position: Q3 2026 in Review

Eastern Bank increased its Guardant Health (GH) stake by 66% in Q3 2026, buying an estimated $245K and bringing the position to 3,756 shares worth $670K. The position accounts for 0.01% of the portfolio, ranked #244.

Eastern Bank first reported a position in GH in Q3 2025 and has held it in 5 quarters since. 511 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • Eastern Bank held 3,756 shares of Guardant Health worth $670K as of Q3 2026.
  • Eastern Bank bought 1,500 Guardant Health shares in Q3 2026, an estimated $245K.
  • Guardant Health made up 0.01% of Eastern Bank's portfolio in Q3 2026, its #244 holding.
  • Eastern Bank first reported a position in Guardant Health in Q3 2025 and has held it in 5 quarters since.
  • 511 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.